Neurovascular Stent
- UID
- IMP/MD/2019/000486_3913dc6b8c05895a3dace9b711e83551_573fa0d1fec8779dc2c04fd76cb48465
- Device class
- Class D
- Brand name
- Aperio® Hybrid Thrombectomy Device
- License holder
- Morulaa Health Tech Pvt Ltd
- Approving authority
- CDSCO
- Product information
- "Used in combination with the NeuroSpeed® PTA Balloon Catheter, the CREDO® Stent is indicated to increase the vessel diameter of intracranial arteries (Aperio® Hybrid Thrombectomy Device) that are suitable for and accessible to the system (Aperio® Hybrid Thrombectomy Device) in patients: • with arteriosclerotic (Aperio® Hybrid Thrombectomy Device) vessel constrictions (Aperio® Hybrid Thrombectomy Device) with significant circulatory disturbance (Aperio® Hybrid Thrombectomy Device), • with recurrent symptoms in spite of antiaggregation therapy (Aperio® Hybrid Thrombectomy Device) after at least two events (Aperio® Hybrid Thrombectomy Device). • aged 18 to 80. • whose last stroke occurred at least 7 days before and in whom the impairment after stroke has a rating of 3 or less on the modified Rankin scale (Aperio® Hybrid Thrombectomy Device) at the time of treatment."
Neurovascular Stent is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2019/000486_3913dc6b8c05895a3dace9b711e83551_573fa0d1fec8779dc2c04fd76cb48465. This device is marketed under the brand name Aperio® Hybrid Thrombectomy Device. The license holder is Morulaa Health Tech Pvt Ltd, and it is classified as Device Class Class D. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.